ARTICLE SUMMARY:
Population health is not on the radar of most medical device companies, although there are some early initiatives in the orthopedics industry. While it is a cornerstone of health care payment reform, its main impact to date has been largely on providers. The medical industry may need to shift, however, according to an interview with David Nash, MD, a primary care physician and the founding dean of Thomas Jefferson University’s College of Population Health.
Population health is not on the radar of most medical device companies, for understandable reasons: while it is a cornerstone of healthcare payment reform, its main impact to date has been largely on providers.
